Changes in subclinical organ damage vs. in Framingham risk score for assessing cardiovascular risk reduction during continued antihypertensive treatment: A LIFE substudy Academic Article uri icon

Overview

MeSH Major

  • Antihypertensive Agents
  • Cardiovascular Diseases

abstract

  • Cornell product(1year) and UACR(1year) improved in contrast to FRS(1year) risk prediction based on FRS(baseline), Sokolow-Lyon(baseline) and UACR(baseline) significantly in LIFE patients during antihypertensive treatment.

publication date

  • May 2011

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1097/HJH.0b013e328344daa3

PubMed ID

  • 21358415

Additional Document Info

start page

  • 997

end page

  • 1004

volume

  • 29

number

  • 5